A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Telix Pharmaceuticals (Innovations) Pty Limited
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Beijing Tiantan Hospital
UMC Utrecht
The Children's Hospital of Zhejiang University School of Medicine
Pfizer
Baptist Health South Florida
GT Medical Technologies, Inc.
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Essen Biotech
Essen Biotech
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Stemline Therapeutics, Inc.
Medical University of South Carolina
Iambic Therapeutics, Inc
Uppsala University
Australian & New Zealand Children's Haematology/Oncology Group
Mayo Clinic
University of Maryland, Baltimore
Telix Pharmaceuticals (Innovations) Pty Limited
Dysplasia Diagnostics Limited
Var2 Pharmaceuticals
Institut du Cancer de Montpellier - Val d'Aurelle
Odense University Hospital
Ottawa Hospital Research Institute
Cancer Research UK
Nested Therapeutics, Inc
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Xiangya Hospital of Central South University
RefleXion Medical
Plus Therapeutics
University of Milano Bicocca
Chipscreen Biosciences, Ltd.
Sklifosovsky Institute of Emergency Care
University Hospital, Basel, Switzerland
Tata Memorial Centre
Northwell Health
Northwell Health
Centre Hospitalier Universitaire de Saint Etienne
Institut du Cancer de Montpellier - Val d'Aurelle
Stanford University
The New York Proton Center
Novelwise Pharmaceutical Corporation